Salmonella Outbreak Linked to Powder Capsules Sickens Seven Across Seven States

Federal health officials are investigating the multistate outbreak tied to Rosabella-brand moringa powder capsules.

Published on Feb. 15, 2026

The FDA and CDC are investigating a multistate salmonella outbreak linked to Rosabella-brand moringa powder capsules distributed by Ambrosia Brands LLC. Seven people across seven states have fallen ill, with three hospitalizations reported. The outbreak involves Salmonella Newport, which may be resistant to common antibiotics.

Why it matters

This outbreak highlights the potential risks of dietary supplements and the need for robust safety regulations. Salmonella infections can be serious, especially for vulnerable populations, and antibiotic resistance makes treatment more challenging.

The details

The capsules, advertised as beneficial for sleep, joint health, and energy, have been traced as the source of the Salmonella Newport outbreak. Illnesses began between November 2025 and January 2026. Ambrosia Brands LLC has agreed to recall specific lots of the Rosabella-brand moringa powder capsules sold online through various retailers.

  • Illnesses began between November 7, 2025, and January 8, 2026.
  • The FDA and CDC announced the investigation on February 15, 2026.

The players

Ambrosia Brands LLC

The company that distributed the Rosabella-brand moringa powder capsules linked to the salmonella outbreak.

FDA

The U.S. Food and Drug Administration, which is investigating the multistate salmonella outbreak.

CDC

The Centers for Disease Control and Prevention, which is also investigating the multistate salmonella outbreak.

Got photos? Submit your photos here. ›

What’s next

The FDA has recommended that Ambrosia Brands LLC recall all Rosabella-brand moringa powder capsules, and the company has agreed to recall specific lots. Consumers and retailers are urged to check their bottles and avoid eating, selling or distributing any capsules with the affected lot codes.

The takeaway

This outbreak underscores the importance of rigorous safety standards and oversight for dietary supplements, as well as the need for consumers to be cautious about the products they ingest, especially those making unsubstantiated health claims.